US Unveils Donation Plans For 25 million Covid-19 Vaccine Doses, Removes Raw Material Restrictions For AstraZeneca, Novavax and Sanofi Vaccines

by Swarajya Staff - Jun 4, 2021 10:13 AM +05:30 IST
US Unveils Donation Plans For 25 million Covid-19 Vaccine Doses, Removes Raw Material Restrictions For AstraZeneca, Novavax and Sanofi VaccinesUS President Joe Biden 
Snapshot
  • The United States today announced its framework for sharing at least 80 million unused vaccine doses globally by the end of June and the plan for the first 25 million doses.

    The White House also announced that it is lifting restrictions on sharing vaccines produced by AstraZeneca, as well as Sanofi and Novavax, which are also not authorized in the U.S., allowing the companies to determine themselves where to share their doses.

The United States today announced its framework for sharing at least 80 million unused vaccine doses globally by the end of June and the plan for the first 25 million doses.

75% of COVID-19 vaccines will be distributed through the U.N.-backed COVAX global vaccine sharing program.

Of the first tranche of 25 million doses, the White House announced about 19 million will go to COVAX, with approximately 6 million for South and Central America.

7 million doses have been earmarked for Asia including India, Nepal, Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Malaysia, Philippines, Vietnam, Indonesia, Thailand, Laos, Papua New Guinea, Taiwan, and the Pacific Islands.

Approximately 5 million for Africa will be shared with countries that will be selected in coordination with the African Union, the US said

"6 million will be targeted toward regional priorities and partner recipients, including Mexico, Canada, and the Republic of Korea, West Bank and Gaza, Ukraine, Kosovo, Haiti, Georgia, Egypt, Jordan, Iraq, and Yemen, as well as for United Nations frontline workers." the White House announced.

The first trance of donated doses will come from a stockpiled mix of Pfizer, Moderna and Johnson & Johnson’s shots

U.S President Joe Biden has announced in late April that the US would send 60 million doses of AstraZeneca‘s vaccine abroad by July 4 . The administration said on Thursday it is not still ready to announce where the 60 million AstraZeneca doses will go, because the FDA safety review is still pending. The FDA is still determining whether the AstraZeneca doses made by contract manufacturer Emergent are contaminated

White House also announced that the government is also removing Defence Production Act priority ratings for vaccines from AstraZeneca, Novavax and Sanofi given that US is confident of its domestic vaccine supply situation.


Get Swarajya in your inbox everyday. Subscribe here.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Comments ↓
Get Swarajya in your inbox everyday. Subscribe here.
Advertisement

Latest Articles

    Artboard 4Created with Sketch.